PHILADELPHIA, Aug. 28, 2018 /PRNewswire-PRWeb/ -- Pentec Health, Inc., an established leader in patient-specific and sterile compounding (503A), announced the availability of multiple products using ...
"We are excited to add Norepinephrine to expand our list of products that help bring flexibility to the hospital IV needs," said Joseph Cosgrove, Chairman, President, and CEO of Pentec Health. Mr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results